Search for: "LUPIN LTD." Results 61 - 80 of 131
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 May 2011, 11:59 pm
Wyeth has also reached agreements with other companies as well, including Sun Pharma, Lupin, Aurobindo Pharma, Ranbaxy and Teva. [read post]
27 Apr 2011, 4:55 am by Marie Louise
(IP Watch) China: Pfizer starts R&D in China after IPR in China challenges (IP Dragon) UK: IPO inviting comment on C-630/10 University of Queensland, CSL Ltd v Comptroller-General of Patents, Designs and Trade Marks and C-130/11 Neurim v Comptroller General of Patents (The SPC Blog) (The SPC Blog) US: New generics quickly grab 80% of sales volume (GenericsWeb) Products Actos (Pioglitazone) – US: Takeda agrees to dismiss one Actos infringement suit against Apotex (Patent Docs)… [read post]
6 Apr 2011, 12:18 am by Marie Louise
427/09 Generics (UK) Ltd v Synaptech Inc (The SPC Blog) Simcor (Niacin, Simvastatin) – US: Abbott files patent infringement complaint against Watson following Para IV certification filing (Patent Docs) Thalomid (Thalidomide) – US: Decision in Lannett Thalomid bioequivalence study sample antitrust lawsuit could reignite debate on generic drug availability and REMS restrictions (FDA Law Blog) Yasmin (Drospirenone, Ethinylestradiol) – UK: Bayer Yasmin patents survive patent… [read post]
3 Apr 2011, 9:44 pm by Patent Docs
• Defendants: Lupin Ltd.; Lupin Pharmaceuticals Inc. [read post]
29 Dec 2010, 2:57 am by Marie Louise
Pfizer Ltd (Kluwer Patent Blog) Boniva (Ibandronate) – US: Roche dodges Cobalt invalidity contention in Boniva patent suit (Patent Docs) Boniva (Ibandronate) – US: Hoffman-La Roche files patent infringement suit against Mutual Pharmaceutical Company following Para IV certification filing (Patent Docs) Botox (Botulinum) – EU: General Court confirms declarations of invalidity of BOTOLIST and BOTOCYL filed by Allergan: T-345/08 and T-357-08 (Class 46) Detrol (Tolterodine)… [read post]
24 Nov 2010, 12:37 am by Kelly
General Global pharmaceutical linkage regulations: A consortium framework (IP Osgoode) Pfizer rolling out generics to grab off-patent market (GenericsWeb) Australia: Too little too late: CSL Limited v Novo Nordisk Pharmaceuticals Pty Ltd (No 2) and the judicial discretion to amend a patent (IP Whiteboard) Brazil: You lost your chance! [read post]
1 Nov 2010, 11:41 am by The Docket Navigator
Lupin, Ltd. et al., 2-10-cv-00080 (NJD October 27, 2010, Order) (Hochberg, J.). [read post]
10 Oct 2010, 9:36 pm by Patent Docs
Pharmaceuticals International C.V.; Northwestern University • Defendants: Lupin Ltd.; Lupin Pharmaceuticals Inc. [read post]
10 Aug 2010, 8:44 pm by Marie Louise
  General Coverage of anti-counterfeit policy debate varies widely across global media (IP Watch) WHO declares flu pandemic over; experts behind response to be revealed (IP Watch) Australia: TGA to implement alert system for new ARTG registrations (IP Whiteboard) EU: Final petition of the Advocate-General / Jodosulfuron- SPC for plant protection products (EPLAW) India: Parliamentary Committee on Health tables report on issues relating to availability of generic medicines (Spicy IP) Peru:… [read post]
8 Aug 2010, 8:32 pm by Patent Docs
Ranbaxy Laboratories Ltd. et al. 2:10-cv-03897; filed August 4, 2010 in the Eastern District of Pennsylvania • Plaintiff: Lupin Atlantis Holdings S.A. [read post]
25 Jul 2010, 9:14 pm by Patent Docs
• Defendants: Lupin Pharmaceuticals, Inc.; Lupin Ltd. [read post]
19 Jul 2010, 1:12 pm by FDABlog HPM
  In contrast, the Federal Circuit’s 1990 decision in Glaxo Operations UK Ltd. v. [read post]